Fig. 4
The study of EMT reversion after therapy. Immunohistochemistry of EMT markers (including E-Cadherin, N-Cadherin, Vimentin and Fibronectin) of tumor slices collected from different groups of mice at day 21 post treatment (including saline control, SPN-GIP with Laser, 177Lu-SPN-GIP, and 177Lu-SPN-GIP with PTT). +  + , + , ± ,-respectively represent strong positive, positive, weakly positive and negative expression of the marker. Scale bar: 200 μm